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Overview 
 
Sub-Saharan Africa has the highest number of children living with HIV. HIV is one of 
the major causes of under-five mortality in Africa.  Antiretroviral therapy in the 
paediatric population has improved mortality, led to a better quality of life, as well as 
overall health and well-being of children. Adherence is a critical factor in determining 
treatment outcomes and success. Non-adherence to therapy increases risk of 
treatment failure, delays immunological recovery and increases opportunistic 
infections.  
In the paediatric population, there is a paucity of studies assessing adherence rates, 
particularly in resource limited settings. Adherence behaviour is found to be more 
complex in children. A number of factors affect adherence in children.  These include 
socio-economic factors, medication factors as well as healthcare provider dynamics. 
 
The purpose of this secondary analysis of a prospective study was to describe 
adherence in a cohort of children attending a regional hospital in Kwa-Zulu Natal, 
South Africa, from September 2006 until October 2009. This study also examined 
factors associated with adherence such as age of the child, gender, as well as the 
role of the primary caregiver.  Since there is no “gold standard” for assessing 
adherence to antiretroviral therapy, this area of research needs to be explored 
further. Secondly, assessing factors associated with adherence will assist in looking 
at ways to improve treatment outcome. 
 
In the main study, prospective patients who were treatment naïve and met criteria to 
commence antiretroviral therapy were identified in outpatients and clinics. Baseline 
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and follow-up questionnaires were used to capture information including adherence 
details over the preceding week as well as since the last visit to hospital. Adherence 
was assessed using the method of verbal recall. Missed doses and the reasons for 
these were recorded and analysed.  Additional factors possibly associated with 
adherence were also recorded and analysed further. 
 
This study reported an overall adherence rate of 94 per cent, similar to rates 
reported in other studies.  Adherence rates over the past week as well as since the 
patient’s last visit were similar. There was a substantial degree of agreement 
between verbal recall for the preceding week as well as since the last visit (kappa 
statistic 0.64, p < 0.005). It was found that children older than five years were more 
likely to be adherent than those under five years (OR 0.871, 95 % CI 0.22-3.376) 
and males were twice as likely to adhere as females (OR=2.05, 95% CI 0.49 -8.59).  
 
The impact of this study is that it will provide information on adherence in children in 
Kwa-Zulu Natal, South Africa.  This could encourage other such studies to be 
undertaken to improve adherence rates and hence treatment success. By examining 
factors associated with adherence as well as identifying possible barriers, we may 
improve treatment success in children.  
 
Adherence to antiretroviral therapy is important, especially in the paediatric 
population as it is shown to increase survival, improve immunity, as well as help 
prevent the development of opportunistic infections. Sub-optimal adherence is 
associated with treatment failure and drug resistance. The use of verbal recall as a 
measure of adherence is useful in a resource limited setting. 
6 
 
Table of contents 
 
Declaration……………………………………………………………………………… ii 
Dedication………………………………………………………………………………… iii 
Acknowledgements……………………………………………………………………… iv 
Overview of the 
thesis……………………………………………………………………………………… v 
Table of 
Contents……………………………………………………………………………………vi 
Chapter 1: The Review of 
Literature………………………………………………………………………………… I 
Chapter 2: A submission ready 
manuscript……………………………………………………………………................. II 
Appendices………………………………………………………………………………  III 
Appendix 1: The final Study Protocol (Include the final protocol which was given full 
approval by Brec and/or the postgrad 
office)…………………………………………………………………………………….. IV 
Appendix 2: The Guidelines for Authorship for the Journal selected for submission of 
the manuscript………………………………………………………………………. V 
Appendix 3: Ethical approvals…………………………………………………………..VI 
Appendix 4: Data collection tool…………………………………………………………VII 
Appendix 5: Raw data…………………………………………………………………… VIII 
 
  
 
7 
 
Chapter 1:  
 
Literature review 
 
According to UNICEF, there were 36.9 million people globally living with HIV at the 
end of 2014. Sub-Saharan Africa bears 91% of the global burden of the disease. HIV 
and AIDS estimates for 2014 revealed that there were 6 800 000 people living with 
the disease in South Africa. The number of children between the ages of 0 – 14 was 
340 000 [1]. As of June 2015, there were 15.8 million people accessing antiretroviral 
(ARV) therapy. There has been a 58% decrease in new HIV infections among 
children since 2000. Worldwide, approximately 220 000 children became newly 
infected with HIV in 2014 [2].  
 
The majority of children are infected with HIV via mother-to-child transmission either 
during pregnancy, labour or breastfeeding. In 2002, a Prevention of Mother-to-Child 
Transmission programme (PMTCT) began in South Africa. In 2010, the Department 
of Health revised the PMTCT policy to include daily nevirapine for six weeks for all 
infants born to HIV-Positive women and to be continued for breastfeeding mothers 
who were not on ART to reduce post-natal transmission [3]. Accordingly, the mother-
to-child transmission rates decreased to 2.7% in 2011 [3].               
                
 The National Consolidated Guidelines for the prevention of mother-to-child 
transmission of HIV and the management of HIV-infected children, adolescents and 
adults in 2015 recommended birth PCR HIV testing of all HIV-exposed neonates, to 
be repeated at ten weeks and rapid HIV testing at eighteen months. For those on 
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extended twelve-week nevirapine, the PCR is to be repeated at eighteen weeks and 
a rapid HIV test at eighteen months. The goal is to initiate treatment early and allow 
for more opportunities to test both mother and child. 
 
There has been a significant upscaling of the ART programme in South Africa. On 1 
April 2004, ART initiation began at several service points across the country. By 
March 2005, all provinces had begun initiating ART. From then on, there have been 
advances in care and delivery to all HIV-infected patients. In 2010, the South African 
Department of Health revised its ARV guidelines, expanding treatment to all children 
under one year of age, all pregnant women regardless of CD4+ count and all TB-HIV 
co-infected patients with a CD4+ count of <350. Only 55% of adults and 36% of 
children eligible for ART were receiving it by the end of 2010 [4]. In 2012, a decision 
was made to expand access thresholds for children [4]. 
 
 ART suppresses HIV replication, prevents opportunistic infection, improves well-
being of children and adults and increases life expectancy. Hence, assessing the 
level of adherence is important as non-adherence will affect treatment outcomes. 
Despite this, the UNAIDS Gap Report 2014 revealed that 62% of children living with 
HIV have not accessed treatment [5].  
 
In the Children with HIV Early Antiretroviral (CHER) trial, early ART was compared 
with a deferred approach in infants <12 weeks of age and with a baseline CD4 count 
of more than 25%. Infants entered the trial at a median of seven weeks of age [6]. 
Children on early therapy had a significant reduction in mortality and disease 
progression. There was also an improvement in developmental outcomes. In an 
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earlier multi-cohort study in 2008, of seven public sector paediatric ART programmes 
in Gauteng, Western Cape and KwaZulu-Natal provinces, outcomes of the South 
African National Antiretroviral Treatment programme for children were looked at. 
Dramatic clinical benefit was seen, with suppression of viral load and a low mortality 
rate of 7.7% in a large cohort of 6078 children. These studies demonstrate the 
success of ART in children as well as significant reductions in morbidity and mortality 
[7].   
 
In a study by Meyers et al., examining ART responses in children attending a large 
public clinic in Soweto, South Africa, it was found that 84% – 96% of children 
achieved virological suppression by 12 – 24 months [8]. Furthermore, after ART 
initiation, immunological improvement was demonstrated by the mean CD4% having 
doubled within twelve months, rising from 12.7% (95% CI: 11.9%, 13.4%) at 
baseline, to 25.1% (95% CI: 24.4%, 25.8%). Growth parameters were also found to 
have improved after initiation of ART [8]. In another South African study in KwaZulu-
Natal by Reddi et al., outcomes of ART in 151 patients were scrutinised. Similarly, 
these patients had an improvement in clinical and immunological parameters on 
commencement of ART. There was an increase in the cohort’s CD4% from baseline 
at six months (p <0.001). Viral load for 100 children at six months revealed 84% 
(95%CI 80.3–87.7) had undetectable levels. In all, 65 out of a total of 88 children 
(73.8%) had a  significant increase (P < 0.001) in weight for age Z-score after the 
first month of treatment [9]. 
The World Health Organisation (WHO) defines adherence as the extent to which a 
person’s behaviour—taking medication, following a diet, and/or executing lifestyle 
changes, corresponds with agreed recommendations from a healthcare provider 
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[10].  Adherence and compliance have been used interchangeably in clinical practice 
and essentially refers to patients’ efforts to follow healthcare advice. HIV is a chronic 
condition for which therapy is for a lifetime. Adherence also encompasses health-
related behaviours that extend beyond taking prescribed medication. Seeking 
medical help, taking medication appropriately and timeously, attending follow-up 
appointments, and executing behavioural modifications are all examples of 
therapeutic behaviour patterns. At the US Centres of Disease and Control (CDCs) 
Noon Conference in 2013, medication adherence was defined as: “The patient’s 
conformance with the provider’s recommendation with respect to timing, dosage, and 
frequency of medication-taking during the prescribed length of time.” 
 
Adherence may be measured using either process-oriented or outcome-oriented 
definitions. Outcome-orientated definitions use the end-result of treatment, e.g., cure 
rate, as an indicator of success. Process-orientated indicators make use of 
intermediate variables such as keeping appointment or pill counts to measure 
adherence [10]. Excellent adherence is one of the most important factors when it 
comes to treatment success.  
 
Inadequate adherence increases the risk of drug resistance. In addition, treatment 
failure and increased hospitalisations intensify the risk of opportunistic infections.  
Virological failure is associated with suboptimal adherence levels. In a study by 
Kamya et al., investigating  the predictors of long-term viral failure among Ugandan 
children and adults treated with ART, it was found that children were almost twice as 
likely to have viral failure compared with adults (26% vs. 14%; P = 0.0001) [11]. 
Adherence is seen as the most significant challenge to children receiving ART. 
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Reasons for this include the child’s reliance on the caregiver, the nature of the 
medication and the child’s reluctance to take medication on a daily basis. 
 
It is noted in paediatric studies that adherence to ART in children is suboptimal, and 
relatively few estimates of adherence to ART have been published in children, 
especially in Africa. In an earlier systematic review by Vreenan et al., undertaken 
among a cohort of children in Western Kenya, adherence estimates ranged from 
49% to 100% [12]. Simoni et al., reviewed fifty studies in the area of paediatric HIV 
infection, which revealed varying methods for assessing ARV adherence with a wide 
range of estimates of adherence. Estimates in this review varied widely from 20% – 
100% [13].  
 
Good adherence is a predictor of virological suppression and treatment success. 
Sub-optimal adherence may increase likelihood of drug resistance as well as 
increased risk of opportunistic infections. Adherences rates of more than 95% have 
been associated with virological suppression [14].  
 
Measures of adherence to ART include caregiver self-report in the form of verbal 
recall, pill counts, diary records, plasma drug concentrations, as well medication 
event-monitoring systems. Drug monitoring in the form of viral load testing are 
thought to be more objective and yield better assessments, whereas methods such 
as pill counts and self-reporting tend to be less reliable and over-estimate 
adherence. Upon reviewing the literature, there is no ‘gold standard’ for the 
measurement of medication adherence in the paediatric population. In children, 
caregiver reporting is the most common method of assessing adherence. 
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Questioning that is structured and goal-directed is thought to yield accurate 
information about adherence [15].  
 
In this prospective study, we used verbal recall as a measure of adherence. It is a 
method that can be used in a resource limited setting. It is commonly used in studies 
reporting adherence to ART in children. This measure reports a higher level of 
adherence than other methods [12]. In a study in Kampala by Nabukeera-Barungi et 
al., adherence in children using ART was measured using a three-day self-report, as 
well as clinic-based pill counts and unannounced pill counts. The three-day self-
report of >95% adherence was 89.4%. Using clinic-based pill counts, 94.1% of 
children had >95% adherence to treatment compared with 72% by unannounced pill 
counts. This study was also in agreement that self-reporting over-estimates 
adherence by 20 – 25% [16].  
 
In a study looking at adherence to ART in young children in Cape Town South Africa, 
methods such as medication return and caregiver report were used. This was a 
prospective study. Adherence by medication return was measured monthly. 
Adherence by questionnaire was measured after the child had completed three 
months of ART. Some 80% of the children obtained average medication return 
adherence of ≥90%. In terms of the use of the questionnaire, missing ≥ 1dose in the 
previous three days was present in 13.8% of children [17]. While this study 
demonstrated that good adherence is possible in young children using simple 
measures, it has to be viewed in the context that strict social inclusion criteria had to 
be met, which aided in improved adherence.  
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A cross-sectional survey was conducted in Mekelle, Ethiopia, by Eticha et al., looking 
at caregiver-reported adherence to ART among HIV infected children in two 
hospitals, from February to March 2013. A structured questionnaire was 
administered to caregivers to assess patient’s adherence. The sample size 
comprised of 193 participants. Adherence assessment was based on caregivers self-
reports in the past three and seven days prior to the interview. Participants who 
reported an intake of ≥95% of the prescribed medication were considered adherent 
and those with a reported intake of <95% were deemed non-adherent. Similar to our 
study, the questionnaire administered included the patient’s demographic details, as 
well as the caregiver’s details. In this study, adherence rates by caregiver reporting 
were 89.1% in the past three days and 83.4% in the past seven days before the 
interview [15]. While these rates are lower than that reported in our study, they are 
comparable to other studies conducted in Africa. 
 
 Biressaw et al., also reported adherence rates comparing unannounced home-
based pill count versus caregivers’ report in 210 children between 1 December 2011 
and 30 January 2012, on ART attending the paediatric ART clinic of Tikur Anbessa 
Hospital (TAH), Addis Ababa University. Caregivers were interviewed using a 
structured questionnaire. Caregiver-reported adherence was found to be 93.3% [18]. 
 
The adherence rates reported by caregiver self-report are shown in studies to 
possibly be over-estimated and higher than other methods. In a study by Vreeman et 
al., in a cohort of children on ART in Kenya, adherence rates with caregiver reporting 
was as high as 92%. They did note however that the caregiver reported adherence 
to study staff became less biased and more accurate as the study progressed. 
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Caregiver-reported adherence was found to be significantly higher than adherence 
by the medication event monitoring system (MEMS). There was poor agreement 
between caregiver-reported missed doses and MEMS [12]. 
 
There is a marked paucity of data in the body of literature describing adherence 
among children. In a qualitative systematic review published in Pediatrics, only eight 
studies, on a smaller scale, evaluated highly-active ART adherence interventions in 
children [13]. While caregiver reports were the least expensive and most widely-used 
methods, they did tend to overestimate adherence rates as compared to other 
methods. Caregivers were prone to recall bias. Self-reports among older children 
were noted to be subject to their cognitive abilities and developmental level. Children 
are cared for by many different caregivers. The guardian, grandparents or other 
family members may have incomplete information about the specifics of the 
medication given to the child and thus make reporting less reliable. The review 
concluded that future research should not only focus on evaluating the validity of 
self-report adherence measures—as these are practical and widely-used tools—but 
also compare this approach to other methods of assessing adherence in the 
paediatric population. 
 
Our study is one of the few studies looking at adherence in a cohort of South African 
children. While most studies have been undertaken in the adult population on ART, 
our study utilised the method of verbal recall to assess adherence in a cohort of 
children in KwaZulu-Natal, South Africa. A high level of adherence was noted and 
suggests further studies need to be done in our setting to better assess adherence. 
Our study also reported on secondary factors associated with adherence, including 
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the role of the primary caregiver and the gender and age of the child. While these 
factors have also been reported on in previous studies, our work is unique in that 
little research has been done on treatment-naïve patients and follow-up undertaken. 
Our study had a long duration of follow-up over time so as to better-assess 
adherence over a prolonged period of time. The longer study period also allowed the 
assessment of change in adherence levels over the follow-up months and to identify 
possible reasons as to why patients were not adherent.  
 
More novel ways of measuring adherence to ART in the paediatric population is for 
example by the Medication Event Monitoring System (MEMS). A prospective study 
of adherence in a paediatric HIV outpatient clinic in Cape Town, South Africa was 
conducted, assessing adherence using MEMS as well as caregiver self-reporting. 
The MEMS system comprised of pressure-sensitive microchip-equipped bottle caps 
which recorded the time and date of all bottle-opening events as presumptive doses 
taken by the patient. The data was stored in the chip and then downloaded to a 
computer and further analysed. In this study, Lamivudine and Abacavir syrup were 
used as MEMS monitored medication. In this cohort, median adherence by MEMS 
was 87.5%, and was found to be associated with virological suppression. Caregiver 
self-report adherence rate was 91%. This study concluded that MEMS was an 
accurate measure of adherence [19]. However, there were some limitations to this 
method. The bottles were not leak-proof and this made handling difficult. Second, the 
longer the caps were in use, the more syrup crystallised on the screw of the bottle 
neck and the cap, which made opening and closing of the cap tedious. Third, and 
more importantly, the cost of such a system is a significant limiting factor and may 
not be feasible in our setting. 
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In a study undertaken by Vreeman et al., looked at assessing adherence in children 
using the method of caregiver self-report, plasma drug concentrations as well as 
MEMS, median adherence by MEMS was reported to be 96.3%. Adherence 
estimates by caregiver report doses using the three-day and seven-day recall was 
92%. This was similar to the adherence rates reported in our study. Of particular 
note, there was poor agreement between MEMS and other adherence measures 
(Kappa Statistics 0.04). In the above-mentioned study, Nevirapine and Efavirenz 
drug concentrations were taken at two time points (month 1 and month 4) during the 
study period. It was found that significant numbers of children had sub-therapeutic 
and supra-therapeutic drug levels. Sub-therapeutic levels are associated with drug 
resistance and virological failure. Drug concentrations did not correlate well with 
MEMS assessment of adherence due to several factors. Measuring these drug 
levels may not be a feasible option in a resource limited setting and may also be 
affected by several factors [12]. One strong criticism of this study is the lack of viral 
load testing which was stated as not being done due to financial constraints. 
Assessing viral load suppression is considered an important outcome in adherence 
to ART. 
 
In an earlier study in a cohort of children of children in West Africa by Elise et al., an 
undetectable viral load was obtained for 55% of the patients with full adherence but 
for none of the patients with non-adherence (P = 0.098) [20]. Viral load testing is 
costly in resource-limited settings. Furthermore, obtaining blood samples in children 
is a challenge. While seen as an objective measure of adherence to ART, due to 
financial constraints, it was not a cost effective method of assessing adherence. 
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A secondary objective in our study was to examine factors associated with 
adherence outcome in young children. These factors include the socio-demographic 
background of the child and caregiver, regimen factors, as well as factors that are at 
an institutional level. 
 
Age plays a role as a factor associated with adherence, and was one of the 
characteristics examined in this study. A very young child is totally dependent on 
her/his caregiver for the administration of medication. Toddlers and pre-school going 
children may refuse to take medication on an ongoing basis. School-aged children 
may develop the capacity to understand their disease process and the need for 
treatment. Adolescent children may find themselves missing medication in a bid to fit 
in, and there is the use of alcohol and drugs which may influence these processes. It 
is also a challenging developmental stage in a child’s life. In a study in Harcourt, 
Nigeria, factors influencing adherence to ART were studied. It was found that 
children younger than five years of age (OR 2.62; 95%CI, 1.30-5.31) was a poor 
predictor of adherence. These children were found twice as likely to be non-
adherent. Reasons for this include their dependence on an adult caregiver as well as 
the challenge of administering medication to very young children [21].  
 
The role of the caregiver also plays a role as a predictor of adherence. Data are 
conflicting on the impact of the caregiver’s biologic relationship to the child. The 
mother may be ill herself and have co-morbid illnesses. However, a biologic 
caregiver may have a better emotional connection with the child and consequently 
may be more motivated to promote good adherence compared with a non-biologic 
caregiver. 
18 
 
 
In cases of vertical transmission, where the biologic parents may have died or may 
be too ill to care for the child, the child then receives care from one or more relatives 
or guardians. In South Africa, there are many such examples of child-headed 
households and even grandmothers undertaking the role of primary caregiver to 
orphaned children. Loss of one or more parents is often complicated with mental 
health issues and multiple caregivers, all of which have been shown to influence 
adherence outcome. Adherence may be sub-optimal due to periods of disrupted 
routines, building of new relationship with the current-caregiver, as well as lack of 
disclosure, among other factors. 
 
In the study in Nigeria, by Ugwu et al., the role of the primary caregiver was also 
examined. It was found that the mother being the primary caregiver was a predictor 
of poor adherence (OR 3.32; 95%CI, 1.33-8.67) [21]. A study in Abidjan, Côte 
d'Ivoire, describing the effect of ART in children revealed that the presence of 
multiple caregivers was associated with poor adherence [20]. 
 
Disclosure is also described in the literature as a challenge and a factor associated 
with adherence. Disclosure of the child’s HIV status, as well as the caregiver’s HIV 
status to family members can help both the child and parent/caregiver to receive 
support for adherence. However, stigma and discrimination possibly associated with 
disclosure are also perceived barriers to adherence. Accordingly, caregivers are 
reluctant to disclose a child’s HIV status to anyone. Disclosure to children about their 
status and clinical condition is challenging. It often depends on the child’s level of 
understanding. Disclosure of HIV status may help these children to understand their 
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illness better as well as their need for treatment and in so-doing increase their 
participation and responsibility for their treatment regimen. A study in Ghana, 
examining the prevalence and pattern of disclosure of HIV status in HIV-infected, 
found the prevalence of disclosure to be 21% in their cohort of children whose ages 
ranged between 8 – 14 years. It was also found that factors associated with 
disclosure include the age of the child, the level of education of child, administration 
of own HIV medications, as well as a longer period on HIV medication [22]. 
 
Some studies have shown male gender to be more associated with better adherence 
outcomes, while other studies have shown no significant association with adherence. 
One such study in Nigeria, in a cohort of children, describing adherence to ART, 
found that males were twice likely to adhere than females (odds ratio: 2.77; CI: 1.17-
6.58) [21]. In a study held in Mulago Hospital, Kampala, Uganda, male gender was 
found not to be significantly associated with adherence rates [16]. 
 
Among other barriers to achieving optimal adherence include medication 
characteristics such as optimal dosage, pill burden, taste of medication and 
administering these to very young children. While syrups allow for proper dosing in 
young children, they can nevertheless be tedious to administer. ARV medications 
generally require frequent dosing and are supplied in formulations that may be 
difficult for children to tolerate. These can also be difficult to keep as some may 
require refrigeration, which in our setting, a number of poorer households may not 
have. Some ARVs need to be taken with food, so caregivers may have to perform 
the task of providing a meal and administering drugs simultaneously, assuming that 
an adequate supply of food is available. Additionally, caregivers may have difficultly 
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administering medication with a syringe [23]. Younger children may refuse to take 
medication due to taste. Gastro-intestinal side-effects may also hinder children 
taking medication and thus have an effect on adherence. 
 
Other social barriers include poverty and food insecurity, especially in the setting of 
Sub-Saharan Africa. In South Africa, twelve million people live in extreme poverty. 
Many HIV-infected children live in poverty and are challenged by food insecurity and 
scarcity. These factors have been associated with poor adherence in developing 
settings [24]. Where primary caregivers to the child are living with HIV and AIDS and 
who themselves are poor, there is an increased risk of food insecurity. Food portions 
decrease as well as the quality and type of food. They may be ill and unable to 
attend work, thus limiting income and productivity. Furthermore, healthcare 
expenditures increase as well as the burden of caregiving. These households 
struggle to meet expenses and may also not make follow-up visits that have been 
scheduled. In a review article by Reda and Biadgilign describing determinants of 
adherence to ART, poverty was noted to be significant in the spread of HIV and 
AIDS as well as adherence. Parents who do not have food to administer with 
medication may not give the medication altogether. Of note, it was also reported that 
transportation costs were also seen as obstacles to taking ART. This resulted in loss 
to follow-up as well as affectation of adherence levels thereof [25].  
 
The ART programme in South Africa has had dynamic changes over the years and 
more children are receiving ART. Furthermore, children are being tested more 
frequently and positive results detected timeously allow for treatment to be 
commenced much earlier in the disease process. Studies have shown that the 
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degree to which patients adhere to their regimen influences its success. Critically 
reviewing the studies carried out, it can be concluded that practical reliable 
measures of adherence can be used in resource-limited settings. Methods such as 
self-reports and diary records, although they tend to over-estimate adherence, are 
still considered to be cost-effective measures of adherence. However, there are 
limited studies that have effectively tested or compared these methods.  
 
Several factors associated with adherence have been identified and examined in the 
literature. These include monitoring of adherence; clinical outcomes as well as 
factors associated with these will allow improvement in strengthening good clinical 
outcome for patients as well as a better patient and healthcare provider relationship. 
This will ultimately improve the quality of life of both children and caregivers. This 
has also paved the way for further research and development in the areas of 
adherence to ART in the paediatric population.  
 
As mentioned previously there is no ‘gold standard’ for assessing adherence in 
young children, and hence this area of research needs to be further explored, 
especially in a resource-limited setting such as South Africa. The importance of 
adherence in this setting needs to be emphasised, in particular to caregivers.  
 
Caregivers also need to understand the necessity and importance of regular follow-
up visits as contact points to reinforce adherence. In our setting, loss to follow-up is a 
common occurrence. Perhaps studies undertaken should include a longer follow-up 
period to assess these further and provide recommendations for patients to keep 
follow-up visits so adherence can be examined on a longitudinal basis. 
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This secondary analysis will be reporting on a study carried out by Meera Chhagan, 
Shuaib Kauchali and Jan Van den Broek in 2012, and aims to shed light about 
adherence as well as factors associated with adherence. 
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ABSTRACT: 
Background: 
Adherence to antiretroviral therapy is required for treatment success.  Excellent 
adherence is one of the most important factors in determining treatment success and 
preventing viral resistance. 
Objectives: 
To describe reported adherence to antiretroviral therapy using the method of verbal 
recall, in a cohort of children in KwaZulu-Natal, and to look at possible factors 
associated with sub-optimal reported adherence.  
Methods: 
This was an analysis of a larger study which was undertaken at King Edward VIII 
Hospital, Durban, on children who were commencing antiretroviral therapy. This 
analysis assessed reported adherence using the method of verbal recall.  A 
structured questionnaire was administered to care-givers to assess reported 
adherence. 
Results: 
The overall reported adherence rate in this study was 94 per cent. There was a 
substantial degree of agreement between verbal recall for the preceding week as 
well as since the last visit (k 0.64, p < 0.005).  In a logistic regression analysis, 
children older than five years were less likely to report reported adherence (OR 
0.871, 95 % CI 0.22-3.376).  Females were twice as likely to report reported 
adherence as males (OR=2.05, 95% CI 0.49 -8.59).   
Conclusion: 
The prevalence of reported adherence to antiretroviral therapy in children, using the 
method of verbal recall, was found to be high in this cohort.   
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Introduction 
The 2014 South African National HIV survey reported KwaZulu-Natal to have the 
highest prevalence rate of HIV infection, an estimated 16.9% [1].  There were an 
estimated 6,800,000 people living with HIV/AIDS in South Africa in 2014. Children 
(0-14years) were estimated at 340,000 [2].  
The South African government approved the national roll-out plan for the 
“Comprehensive Care and Treatment for HIV and AIDS” in November 2003. This 
plan made provision for antiretroviral therapy (ART) within public sector facilities to 
persons with HIV-infection. ART in children has been shown to be effective in 
suppressing the virus, preventing opportunistic infections, and improving the well-
being of children. Excellent adherence is one of the most important factors in 
determining treatment success and preventing viral resistance. The need for optimal 
adherence to lifelong therapy from an early age has been identified as a major 
challenge in the administration of ART to HIV-infected children [3].  At the 
Conference on Retroviruses and Opportunistic Infections (CROI) 2015, statistics 
revealed that almost half of all children and adolescents who were infected with HIV 
were not on treatment [4].  
Children in low and middle income countries often face multiple and complex 
barriers to achieving optimal adherence. It is noted in paediatric studies that reported 
adherence to antiretroviral therapy in children is suboptimal, but relatively few 
estimates of adherence have been published [5].  Furthermore, assessing the level 
of adherence in children in a resource limited setting is also seen as a challenge. 
32 
 
Methods such as self-report, diary records and pill counts have been used. Care-
giver self-report as a measure of reported adherence may be seen as subjective and 
over-estimating adherence. Studies have shown that self-reporting over-estimates 
adherence by 20-25 per cent [6, 7].  However, in a resource limited setting, self-
report as a measure of reported adherence can be viewed as a cheap and practical 
method [8].  
A more novel way of measuring adherence to ART in the paediatric population is 
by the Medication event monitoring system (MEMS). In one such study, at an 
academic hospital in Cape Town, young children with a mean age of 51 months 
were investigated. Reported adherence was monitored electronically over three 
months, and viral loads were evaluated pre- and post-study.  Whilst MEMS may be 
an objective method of measuring adherence, it may not be as cost effective as 
care-giver self-report, diary records or pill counts in a resource limited setting [9].  
There are few studies in children using viral load testing to assess suppression 
[10]. Available studies in children show rates of suppression to be between 27% and 
75%.  In one South African study, virological suppression was lower in children less 
than two years of age.  The method of viral load testing as a marker to assess 
reported adherence is a part of routine care and management. There are initiatives 
by many countries and international donor bodies to roll out affordable viral load 
testing in poorer, less-resourced countries [4, 10].  
Factors associated with poor adherence in children, include whether the mother is 
the primary caregiver and whether psychosocial factors, medication regimens, 
financial burden due to expenses incurred on her own therapy, impact on the child’s 
therapy [11].  The youngest children are most likely to be lost to follow-up. Individual 
patient barriers include low socio-economic status, lack of disclosure and low 
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parental education.  Structural barriers include distance to treatment facility [12].  In 
contrast, some factors promoting reported adherence include family support, 
disclosure and frequent follow-up [7, 11].  In South Africa, there is a high burden of 
disease and co-infection with tuberculosis and HIV. This co-infection also contributes 
to sub-optimal reported adherence. Drug factors such as taste and side-effects may 
also significantly alter adherence levels [13].  
This study was a secondary analysis looking at reported adherence in children in 
a resource limited session using the method of verbal recall as well as factors 
associated with reported adherence [14]. 
Aims and objectives 
The primary aim of the study was to evaluate reported adherence to ART in children. 
A secondary aim was to look at factors which might impact on reported adherence. 
Methods 
Study population and design 
This study was an analysis of data from a prospective study entitled “Metabolic 
and Nutritional effects of anti-retroviral therapy in children. PI: M Chhagan”. 
The parent study was conducted in an urban hospital, King Edward VIII hospital, in 
Durban, Kwa-Zulu Natal, in a cohort of children commencing ART [14]. Only the 
participants who were treatment naïve at the time of initiation were considered for 
enrolment in this study.  Participants who had a willing parent or guardian to give 
informed consent and to comply with the study schedule were included.   
These participants were identified through the PMTCT programme or referred 
from public clinics in areas such as Cator Manor, as well as hospitals beyond the 
catchment area which included Addington Hospital.  Eligible participants for the 
study were identified, recruited and informed consent obtained by study staff.  
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Eligible participants scheduled to commence ART were informed of the reported 
adherence sub-study. 
Inclusion criteria were: children who were commencing ART, treatment naïve at 
the time of initiation, females below 11 years, and males below twelve years, who did 
not exhibit secondary sexual characteristics. This age group was chosen as females 
more than 11 years and males more than twelve years are generally considered to 
be adolescents. Participants had to have a willing parent or guardian to give 
informed consent and be able to comply with the study schedule. Those children 
who did not meet above criteria were excluded. 
Method of data collection 
Data collection was done using baseline and follow-up structured questionnaires 
directed at the primary caregiver. Information was collected by research staff. The 
baseline and follow-up questionnaires were in written format. It was available in the 
English language. It was designed for this particular study. Each child underwent a 
detailed clinical assessment by a research doctor prior to and during treatment. 
Baseline clinical characteristics of the cohort included demographic details such as 
age, gender, primary caregiver, recent hospitalisations and illnesses, age of co-
trimoxazole prophylaxis initiation, as well as tuberculosis infection history.  This 
information has been previously published by Chhagan et al. [14]. 
Maternal details were also enquired about, including whether the mother was 
alive, age, history of tuberculosis, if mother/primary care-giver was taking 
antiretroviral therapy, as well as any illnesses in the preceding three months. Other 
variables assessed were whether the mother received antiretroviral therapy or 
nevirapine during pregnancy as well as whether the baby had received nevirapine as 
part of prevention of mother to child transmission. 
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Clinical assessment included WHO staging, enquiring about side-effects and 
grading severity, baseline blood investigations including CD4 count, viral load, and 
biochemistry tests [14]. 
The follow-up questionnaire at 1, 3, 6, 9, 12, 18, and 24 months of the study period 
looked at reported adherence details using the method of verbal recall in the form of 
treatment doses/days missed in the past week and since the last visit. If the answer 
to those questions were “yes”, then the treatments doses/days missed were 
recorded as well as reasons for the missed doses/days. 
Additional information in the follow-up questionnaire included recent illnesses, 
hospitalisations, current treatment, side-effects and whether the patient was taking 
other medication.  
Ethical considerations 
Ethical approval was obtained from the Biomedical Research Ethics Committee of 
the University of KwaZulu-Natal for the parent study (Ref: E181/05). The KwaZulu-
Natal Department of Health and medical management of King Edward VIII Hospital 
granted permission for conduct of the study. This study is an analysis of an existing 
database and did not entail any contact with participants.  
 
 
Results 
The data collected from the responses was analysed with SPSS version 23.0. 
Statistical significance was set at a p value < 0.05. From September 2006 to July 
2009, 165 patients were screened at King Edward VIII hospital.  A total of 151 
children were eventually recruited. Demographical data are presented in Table 1. 
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Overall, the ratio of males to females is approximately 1:1. Children older than five 
years of age comprised 48.4% of the cohort. The primary caregiver was the 
biological mother in 73 (49%). 
The mean reported adherence for the preceding week was 94%. The mean reported 
adherence for the recall since last visit was 95.4 per cent.  These were calculated as 
a percentage of the number of doses taken divided by the number of expected doses 
in the preceding week and since last visit respectively. There was a substantial 
degree of agreement between verbal recall for the preceding week as well as the last 
visit (k 0.64, p<0.005). (Figure 1) 
Reported adherence was also compared as a measure over time and was shown 
to improve from the first month onwards.  Various reasons were cited for non- 
adherence. These included forgetting to take medication, early trip to hospital; social 
circumstances such as a death in the family, primary care-giver demised, and drug 
side-effects. One of the reasons also included was a hospital strike. Figure 1 refers 
to the reasons for missing doses as described with percentages.  
A logistic regression model was used to predict a dichotomous categorical 
variable from a set of predictor variables (Table 2.) 
Children who were older than five years of age were found to be less adherent to 
antiretroviral therapy (OR=0.87, 95% CI 0.25-3.33), and males were found to be less 
adherent than females (OR=2.05, 95% CI 0.49 -8.59). The mother being the primary 
care-giver was not associated with reported adherence, (OR=0.72, 95% CI 0.18-
2.92).  
Discussion 
Adherence to ART in children is critical to maximise the success of the drugs. 
Inadequate adherence results in virological and immunological failure. In this study, 
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verbal recall over the past week as well as since the last visit found reported 
adherence rates of 94 and 95.4 per cent respectively.  The overall reported 
adherence rate was 94 per cent. This is similar to adherence rates reported in similar 
studies in African countries [6].  The method of verbal recall may overestimate 
reported adherence levels and could reflect bias from using a caregiver’s report, 
such as social desirability bias or recall bias. Of note, is the improved reported 
adherence over time, which could be as a result of enforcing the need to take 
medication on time and the importance of not missing doses. However, verbal recall 
in a resource-limited setting may be an important method of reported adherence 
support.  
The main reasons given for missed doses included care-giver forgetting, early trip 
to hospital, and death in family as well as side effects. One particular reason cited 
was a hospital strike. These factors represent socio-economic, medication-related 
and health-care related challenges as possible barriers to reported adherence, 
identified in other studies too [13].  In a study in KwaZulu-Natal, South Africa, 
reasons reported for missed doses were: financial barriers that prevented caregivers 
from collecting medication on time, side-effects, incorrect dosing by a caregiver, 
missed follow-up visits and pharmacy collections, confusion as well the child refusing 
to take medication [15].  
Factors associated with reported adherence in this study included the age of the 
child, who the primary care-giver was, as well as the gender of the child.  Children 
older than five years of age, and male gender, were found to have less increased 
likelihood of reported adherence, and this has been shown in reports from other 
studies [13].  In this study, the primary care-giver was not found to be statistically 
significant in influencing reported adherence outcome.  In a study by Ugwa R et al, 
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children with mothers as the primary caregiver were three times more likely to be 
non-adherent.  Reasons for this included the mother having poor health, as well as 
lack of disclosure. This would mean that there would be no one else to administer 
medication if the mother was ill [16].  
There were some limitations to the study namely methods of verbal recall possibly 
over-estimate reported adherence. In addition, the social criteria used to determine 
ART eligibility may have further selected those patients more likely to be adherent. 
The importance of measuring reported adherence to ART in children is to improve 
overall well-being and longevity in patients as well as preventing opportunistic 
infections.  
Conclusion 
This study revealed the prevalence of reported adherence using the method of 
verbal recall over the past week as well as since the last visit to be 94 per cent and 
95.4 per cent respectively. This is comparable to reported adherence rates using the 
method of verbal recall in similar studies. Verbal recall tends to over-estimate 
reported adherence, as demonstrated in other studies as well. However, in a 
resource-limiting setting, this may be seen as a measure of reported adherence to 
improve outcomes over time. Further studies in the paediatric population are needed 
to assess reported adherence and interventions thereof to improve outcomes. 
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Table 1. Children’s demographic characteristics 
Characteristics Frequency (%) n = 151 
Gender 
Male 
Female 
77 (51) 
74 (49) 
Age (years) 
< 2 
2-5 
>5 
41 (27.7) 
37 (24.5) 
73 (48.4) 
Primary care-giver 
Mother 
Other 
73 (48.3) 
78 (51.7) 
 
Table 2: Factors associated with reported adherence 
Factors Reported adherence outcome OR (95%CI) P value 
 
Adherent 
n = 142 (%) 
Non-adherent 
N = 9 (%) 
  
Age of child 
<2 
2-5 
>5 
 
38 (92.6) 
35(94.6) 
69 (94.4) 
 
3 (7.4) 
2(5.4) 
4 (5.6) 
 
0.79 
0.73 (0.18 - 3.07) 
1.2 (0.24 - 5.98) 
0.87 (0.25 - 3.38) 
Gender of child 
Male 
Female 
 
71 (95.9) 
71(92.6) 
 
3(4.1) 
6(7.8) 
2.05 (0.49 -8.59) 0.65 
Primary caregiver 
Mother 
Other 
 
68 (93.2) 
74 (94.9) 
 
5 (6.8) 
4(5.1) 
0.72 (0.18 -2.92) 0.32 
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Figure 1.Reported adherence over the follow-up periods 
 
 
Figure 2. Reasons for missing doses 
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Appendix 1: The final Study Protocol (Include the final protocol which was 
given full approval by Brec and/or the postgrad office) 
 
Title of the study 
Adherence to Antiretroviral therapy in children using the method of verbal recall 
 
Aim of study 
The aim of the study is to evaluate adherence to HAART in children using the 
method of verbal recall over the preceding week, as well as since the last visit. The 
study will be a secondary analysis of data from a prospective study entitled 
Metabolic and Nutritional effects of antiretroviral therapy in children. PI: M Chhagan, 
Paediatrics, BREC Ref: E181/05 that used verbal recall and diary records to 
describe the adherence to HAART, in a resource limited setting. A secondary aim 
would be to look at factors associated with adherence. 
 
 Specific objectives 
• To compare adherence to HAART in children from other studies with this 
study  
• To describe the difficulties associated with adherence to HAART in the 
paediatric population 
• To analyse data from a prospective study of a cohort of children that used 
verbal recall in predicting adherence to HAART  
• To identify factors associated with suboptimal-adherence  
 
Background and literature 
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Approximately 85% of the 2.3 million HIV-infected children under 15 years worldwide 
live in sub-Saharan Africa (Davies, Boulle, Fakir, Nuttall, & Eley, 2008).  Antiretroviral 
therapy in children has shown to be effective in suppressing the virus, preventing 
opportunistic infections, and improving the well-being of children and adults world-
wide.  
Adherence is the process or condition of adhering. Adhering means to be devoted, 
be a follower or to follow closely. Excellent adherence is one of the most important 
factors when it comes to treatment success. Adherence to lifelong therapy however, 
in children, in a resource limited setting has been identified as a major challenge 
(Davies et al., 2008). Factors such as volume, taste, intake of drugs, dosage 
intervals and side effects play a role in the outcome of adherence to antiretroviral 
therapy in children (Iroha, Esezobor, Ezeaka, Temiye, & Akinsulie, 2010).  
It is noted in the paediatric studies that adherence to antiretroviral therapy in children 
is suboptimal, and relatively few estimates of adherence to antiretroviral therapy 
have been published in children. Furthermore assessing the level of adherence in 
children, in a resource limited setting is also seen as a challenge (Steele & Grauer 
2003). Methods such as self-report, diary records and pill counts have been used to 
measure adherence.  
In a study looking at adherence to antiretroviral therapy in young children in Cape 
Town South Africa, methods such as medication return and care-giver report were 
used. This was a prospective cohort study. Adherence by medication return was 
measured monthly. Adherence by questionnaire was measured after the child had 
completed three months of antiretroviral therapy. Eighty per cent of children obtained 
average medication return adherence of ≥90 per cent. In terms of the use of the 
questionnaire, missing ≥ 1dose in the previous three days was present in 13.8 per 
cent of children. Whilst this study demonstrated good adherence is possible in young 
children using simple measures, it has to be viewed in the context that strict social 
inclusion criteria had to be met, and this aided adherence to be quite good.  
Care-giver self-report as a measure of adherence may be seen as a subjective 
method, over-estimating adherence. Studies have shown that self-reporting over-
estimates adherence by 20-25 per cent (Nabukeera-Barungi, Kalyesubula, 
Kekitiinwa, Byakika, & Musoke, 2007). However, in a resource limiting setting, self-
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report as a measure of adherence can be viewed as a cost-effective and practical 
method.  
In a study in Kampala (Nabukeera-Barungi et al., 2007), adherence in children using 
antiretroviral therapy were measured using a three day self-report, as well as clinic 
based pill counts and unannounced pill counts. The 3-day self-report of >95% 
adherence was 89.4%. Using clinic-based pill counts, 94.1%, had >95% adherence 
to treatment compared with 72% by unannounced pill counts. Pill counts can be 
seen as an objective method to measure adherence to ART in children. 
In addition, more novel ways of measuring adherence to ART in the paediatric 
population is for example, by Medication event monitoring system (MEMS). In one 
such study, at an academic hospital in Cape Town, young children with a mean age 
of 51 months (SD 25.6) were investigated (Muller, Bode, Myer, Stahl, & von 
Steinbuchel, 2011). Adherence was monitored electronically over three months, and 
viral loads were taken pre- and post-study.  Whilst MEMS may be an objective 
method of a measure of adherence, however, in a resource limited setting, it may not 
be as cost effective as care-giver self-report, diary records or pill counts.  
It is also possible that different adherence measures might complement each other, 
and increase their sensitivity. Giordano et al found close correlation between various 
adherence measures in adults.  
The principal questions that need to be asked, reviewing the literature, revolve 
around the above-mentioned measures of adherence, their sensitivity and use in a 
resource-limited setting. Adherence of > 95% seems necessary to achieve viral 
suppression and to avoid development of viral resistance (Friedland GH and 
Andrews LA; 2011).   
It is established that success of HAART rests on a high level of adherence to the 
medication, and centres offering HAART services are required to assess the level of 
individual patient adherence (Hardon, Davey, Gerrits, Hodgkin, Irunde, Kgatlwane et 
al., 2006).  For HIV-positive children, sustaining adherence is even more 
challenging. 
There has been an up-scaling of the ART program for HIV-infected children in 
resource-limited settings. Studies have shown that the degree to which patients 
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adhere to their regimen influences its success. Critically reviewing the studies carried 
out, it can be concluded that practical reliable measures of adherence can be used in 
resource limited settings. Methods such as self-report and diary records, though they 
tend to over-estimate adherence, are still considered to be cost effective measures 
of adherence. However there are limited studies that have effectively tested or 
compared these methods. Noteworthy there is a need for a study to be carried out to 
test and measure adherence in children in KZN, South Africa. This study will be 
reporting on a study carried out by Meera Chhagan, Shuaib Kauchali and Jan Van 
den Broek in 2012. 
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Study design 
Study population 
The parent study Metabolic and Nutritional effects of antiretroviral therapy in 
children. PI: M Chhagan, Paediatrics, BREC Ref: E181/05 was carried out at King 
Edward VIII hospital Durban, in a cohort of children commencing HAART.  Inclusion 
criteria were children commencing HAART, females below the age of eleven years, 
and males below the age of twelve years, who did not exhibit secondary sexual 
characteristics. Only the participants who were treatment naïve at the time of 
initiation were considered for enrolment in the study.  Importantly, participants who 
had a willing parent or guardian to give informed consent and to comply with the 
study schedule were included.  A cohort of 151 participants was enrolled into the 
study. Age of the participants ranged from 6.9 to 159.3 months.   
 
 
Sampling strategy 
The parent study Metabolic and Nutritional effects of antiretroviral therapy in 
children. PI: M Chhagan, Paediatrics, BREC Ref: E181/05, recruited participants 
between September 2006 and July 2009, who were commencing HAART at King 
Edward VIII hospital, in Durban, Kwa-Zulu Natal. These participants were 
encountered through the PMTCT programme or referred from various hospitals. 
Eligible participants for the study were identified, recruited and consented by study 
staff.  Eligible participants scheduled to commence HAART were also informed of 
the study. 
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Inclusion/exclusion criteria 
Inclusion criteria were:  
- Children who were commencing HAART 
- Treatment naïve at the time of initiation 
- Females below 11 years, and males below twelve years, who did not exhibit 
secondary sexual characteristics.  
- Participants had to have a willing parent or guardian to give informed consent 
and able to comply with the study schedule 
 
Exclusion criteria: 
- Children who had already commenced HAART 
- Post-pubertal males older than twelve years of age 
- Post-pubertal females older than eleven years of age 
- Participants who did not have a willing parent/guardian giving informed 
consent and not able to comply with study schedule were excluded from participating 
in the study 
 
Data collection methods and tools 
Participants were assessed at baseline, and were followed up at 1, 3,6,9,12,18 and 
24 months after the initiation of HAART.  A structured follow up assessment form 
was used to record various details including maternal and child details, examination 
findings, current investigations as well as adherence details. Adherence to HAART 
was assessed using care-giver verbal recall, diary records, as well as pill counts at 
each visit. For verbal recall, participants were asked about treatment days missed in 
the preceding week, as well as treatment days missed since their last visit.  If the 
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answers were yes to these questions, the number of days missed were recorded, 
with reasons.   
 
Statistical planning 
Predictor variables for the analysis in the proposed MMed study will be adherence 
and non-adherence, measured by verbal recall in the past week as well as since the 
last visit.  These will be used to create categorical variables (outcome is either 
adherent or non-adherent). Adherence will be ascertained on follow-up assessment 
of patients.  
Independent variables will include child factors such as age, gender as well as 
number of hospitalisations before starting HAART. 
Caregiver factors in this study will include relationship to the child such as if the 
mother is the primary care giver, if the caregiver is also receiving ART, and recent 
illnesses of the mother. 
Drug factors that will be assessed are side effects of medication and if there are any 
additional medication taken (these included nutritional supplements and over the 
counter medication). 
 
Sample size 
In the parent study, Metabolic and Nutritional effects of antiretroviral therapy in 
children. PI: M Chhagan, Paediatrics, BREC Ref: E181/05, 154 were deemed 
eligible for the study, however, 151 participants were enrolled.  This cohort included 
74 females and 77 males.  Six children had died during follow up, and thirteen were 
lost to follow up. Eleven children were transferred to other treatment sites for 
continuation of treatment, mainly due to residential proximity. 
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Data Analysis 
Adherence to ante retroviral therapy was assessed using the method of verbal recall.  
A structured follow-up assessment was used to assess adherence to antiretroviral 
therapy in participants, in addition to maternal and child details, as well as 
examination findings and investigations. 
Children were followed up monthly for three months, then 3 monthly until 9 months, 
thereafter 6 monthly until 24 months. 
Adherence proportions (and associated 95% confidence intervals) was calculated for 
each follow up time period to assess temporal changes in adherence patterns. A 
Chi-squared test for trend will be used to detect with a significant decrease in 
adherence occurs over the follow up period.  
Predictor variables in this study will be adherence and non-adherence, measured by 
verbal recall over the past week and last visit.   
For verbal recall, adherence was  assessed by asking participant’s  caregiver  
number of  treatment days missed in the past week, as well as last visit. The options 
being a “yes/No” answer to these questions.  If the answer was “yes”, the number of 
treatment days missed was recorded. Adherence was defined as having taken all 
doses of the ARVs during the past week, as well as since the last visit. If more than 
one treatment day had been missed, then this would be defined as non-adherence.  
Thereafter the percentage of participants that were adherent was measured using a 
dichotomous variable for adherence. 
The main outcome variables in this study will be adherence and non-adherence, 
measured by verbal recall over the past week and last visit.   
Adherence proportions (and associated 95% confidence intervals) will be calculated 
for each follow up time period to assess temporal changes in adherence patterns. A 
Chi-squared test for trend will be used to detect with a significant decrease in 
adherence occurs over the follow up period. 
Most care-givers are likely to report adherence as opposed to non-adherence. 
Therefore, a comparison of the method of verbal recall over the past week versus 
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last visit will be made, to determine which method is likely to report non-adherence. 
The agreement between the two methods will be analysed by McNemar’s test. 
The Kappa statistic will be used to assess the pairwise agreement between verbal 
recall over the past week versus last visit. The following has been proposed as a 
general standard for assessing the strength of agreement for the kappa coefficient:  
≤0poor, .01–.20 slight, .21–.40 fair, .41– .60 moderate, .61–.80 substantial, and .81–
1 almost perfect [Landis and Koch, 1977]. 
Factors associated with non-adherence will be assessed using bivariate logistic 
regressions. These will include independent variables of child factors such as age, 
gender as well as number of hospitalisations before starting HAART. Factors 
associated with a discordant outcome with a p-value cut-off <0.2 based on the 
bivariate associations will be selected for entry into an adjusted multivariable logistic 
model. Significance in the adjusted model will be assessed at p<0.05. Model 
diagnostics (assumptions, fit, influential observations) and predictive qualities 
(sensitivity, specificity, positive predictive value [PPV]) will be assessed. 
Caregiver factors/variables in this study will include relationship to the child such as if 
the mother is the primary care giver, if the caregiver is also receiving ART, and 
recent illnesses of the mother. 
Drug factors assessed will be side effects of medication and if there would be any 
additional medication taken (these included nutritional supplements and over the 
counter medication). 
 
Study location 
King Edward VIII hospital, in Durban, Kwa-zulu Natal, South Africa 
 
Study period 
Between September 2006 – July 2009 
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Limitations to the study 
- In this study, methods of verbal recall may over-estimate adherence 
-  The social criteria used to determine ART eligibility may have further selected 
those patients more likely to be adherent 
- Regular monitoring of adherence in this study may enhance adherence levels, and 
not give a true picture of adherence in the general paediatric population 
 
Ethical considerations 
The parent study, conducted by Principal Investigator Dr Chhagan had full approval 
by the Ethics review Committee of the University of Kwa-Zulu Natal Brec ref: 
E181/05. The MMed study is a secondary analysis of existing data and does not 
entail any contact with participants. The PI will provide a de-identified dataset for the 
MMed analysis. Permission was granted by the Kwa-Zulu Natal Department of 
health as well as the management of King Edward VIII Hospital for the study to be 
undertaken. 
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Appendix 2: The Guidelines for Authorship for the Journal selected for 
submission of the manuscript 
 
Find attached 
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Appendix 3: Ethical approvals 
 
Find attached 
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Appendix 4: Data collection tools (for example) 
 
Find attached 
